Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
BPC-157 and TB-500 Stacked: Dosage Adjustments for the Wolverine Protocol The Wolverine Stack combines BPC-157 with TB-500 (Thymosin Beta-4) in a single cycle designed for patients with significant acute injuries or post-surgical recovery timelines who want to leverage both peptides complementary mechanisms simultaneously
(2012) S-adenosylmethionine in liver health, injury, and cancer, Physiol
PMID: 34703584
Lock JY, Carlson TL, Carrier RL (2018) Mucus models to evaluate the diffusion of drugs and particles
En nuestro GSH Glutatin 100 mg de Bonusan hemos puesto L-glutatin reducido
